Bailly, C.; Gouard, S.; Guérard, F.; Chalopin, B.; Carlier, T.; Faivre-Chauvet, A.; Remaud-Le Saëc, P.; Bourgeois, M.; Chouin, N.; Rbah-Vidal, L.;
et al. What is the Best Radionuclide for Immuno-PET of Multiple Myeloma? A Comparison Study Between 89Zr- and 64Cu-Labeled Anti-CD138 in a Preclinical Syngeneic Model. Int. J. Mol. Sci. 2019, 20, 2564.
https://doi.org/10.3390/ijms20102564
AMA Style
Bailly C, Gouard S, Guérard F, Chalopin B, Carlier T, Faivre-Chauvet A, Remaud-Le Saëc P, Bourgeois M, Chouin N, Rbah-Vidal L,
et al. What is the Best Radionuclide for Immuno-PET of Multiple Myeloma? A Comparison Study Between 89Zr- and 64Cu-Labeled Anti-CD138 in a Preclinical Syngeneic Model. International Journal of Molecular Sciences. 2019; 20(10):2564.
https://doi.org/10.3390/ijms20102564
Chicago/Turabian Style
Bailly, Clément, Sébastien Gouard, François Guérard, Benjamin Chalopin, Thomas Carlier, Alain Faivre-Chauvet, Patricia Remaud-Le Saëc, Mickaël Bourgeois, Nicolas Chouin, Latifa Rbah-Vidal,
and et al. 2019. "What is the Best Radionuclide for Immuno-PET of Multiple Myeloma? A Comparison Study Between 89Zr- and 64Cu-Labeled Anti-CD138 in a Preclinical Syngeneic Model" International Journal of Molecular Sciences 20, no. 10: 2564.
https://doi.org/10.3390/ijms20102564
APA Style
Bailly, C., Gouard, S., Guérard, F., Chalopin, B., Carlier, T., Faivre-Chauvet, A., Remaud-Le Saëc, P., Bourgeois, M., Chouin, N., Rbah-Vidal, L., Tripier, R., Haddad, F., Kraeber-Bodéré, F., Bodet-Milin, C., & Chérel, M.
(2019). What is the Best Radionuclide for Immuno-PET of Multiple Myeloma? A Comparison Study Between 89Zr- and 64Cu-Labeled Anti-CD138 in a Preclinical Syngeneic Model. International Journal of Molecular Sciences, 20(10), 2564.
https://doi.org/10.3390/ijms20102564
